These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8309997)

  • 1. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence.
    Zaidi SI; Oleinick NL; Zaim MT; Mukhtar H
    Photochem Photobiol; 1993 Dec; 58(6):771-6. PubMed ID: 8309997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin.
    Agarwal R; Korman NJ; Mohan RR; Feyes DK; Jawed S; Zaim MT; Mukhtar H
    Photochem Photobiol; 1996 Apr; 63(4):547-52. PubMed ID: 8934768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
    Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
    Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.
    Anderson C; Hrabovsky S; McKinley Y; Tubesing K; Tang HP; Dunbar R; Mukhtar H; Elmets CA
    Photochem Photobiol; 1997 May; 65(5):895-901. PubMed ID: 9155263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy of chemically- and ultraviolet B radiation-induced murine skin papillomas by chloroaluminum phthalocyanine tetrasulfonate.
    Agarwal R; Athar M; Elmets CA; Bickers DR; Mukhtar H
    Photochem Photobiol; 1992 Jul; 56(1):43-50. PubMed ID: 1508981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
    Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
    Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
    Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
    Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells.
    Agarwal ML; Clay ME; Harvey EJ; Evans HH; Antunez AR; Oleinick NL
    Cancer Res; 1991 Nov; 51(21):5993-6. PubMed ID: 1933862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue.
    Lilge L; Portnoy M; Wilson BC
    Br J Cancer; 2000 Oct; 83(8):1110-7. PubMed ID: 10993661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
    Adams K; Rainbow AJ; Wilson BC; Singh G
    J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.
    Reddan JC; Anderson CY; Xu H; Hrabovsky S; Freye K; Fairchild R; Tubesing KA; Elmets CA
    Photochem Photobiol; 1999 Jul; 70(1):72-7. PubMed ID: 10420845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
    Margaron P; Madarnas P; Quellet R; Van Lier JE
    Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia potentiates the effects of aluminum phthalocyanine tetrasulfonate-mediated photodynamic toxicity in human malignant and normal cell lines.
    Glassberg E; Lewandowski L; Halcin C; Lask G; Uitto J
    Lasers Surg Med; 1991; 11(5):432-9. PubMed ID: 1816478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
    Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
    Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
    Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors.
    Chan WS; Marshall JF; Lam GY; Hart IR
    Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.